Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/30/2025

Magnesium Supplementation in Hypokalemia

Patient Populations Requiring Magnesium-First Approach

  • Patients with short bowel syndrome, particularly those with jejunostomy, and patients undergoing continuous renal replacement therapy, especially with regional citrate anticoagulation, require a magnesium-first approach 1
  • Correct sodium and water depletion first to avoid hyperaldosteronism, which can worsen both magnesium and potassium losses 1
  • For oral supplementation, use organic magnesium salts (aspartate, citrate, lactate) due to better bioavailability than magnesium oxide or hydroxide 1
  • For intravenous treatment of severe deficiency, administer 1-2g IV magnesium over 15 minutes 1

Monitoring and Precautions

  • Monitor serum magnesium and potassium levels regularly during replacement therapy 1
  • Avoid excessive magnesium supplementation in patients with renal insufficiency due to risk of hypermagnesemia 1
  • Be aware that serum magnesium levels do not accurately reflect total body magnesium status, as less than 1% of magnesium is found in the blood 1
  • For patients on continuous renal replacement therapy, consider using dialysis solutions containing magnesium to prevent hypomagnesemia 2, 3

Potential Pitfalls

  • Overlooking the need to correct sodium and water depletion before addressing magnesium and potassium deficiencies 1